▲ Up
 
14:45 07-12-2016
MAIN АКИpress CA-News
About us On-line subscription
KazakhstanKyrgyzstanMongoliaTajikistanTurkmenistanUzbekistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug maker Shire rejects offer from AbbVie worth $46 billion
16:29, 20 June 2014, 1140

Bishkek (AKIpress) - drugs The Irish pharmaceutical company Shire said on Friday that it had rejected a takeover approach from the American drug maker AbbVie that valued the company at 27.2 billion pounds, or about $46.3 billion, the NY Times said. 

AbbVie, which is based in Chicago, revealed on Friday that it had first approached Shire in early May about a possible tie-up, but was rejected three times by Shire’s board of directors – the latest at the end of May. AbbVie was spun off from Abbott Laboratories last year.

Shire called AbbVie’s proposal “unsolicited and highly conditional” and said that it “fundamentally undervalued the company and its prospects.”

“We believe that Shire has a strong independent future,” Susan Kilsby, the Shire chairwoman, said in a statement.

Under British takeover rules, AbbVie has until July 18 to make a firm offer for Shire or walk away for at least six months before coming back with a further unsolicited offer. After three months, it is possible for the sides to reengage if Shire’s board agrees to it.

“There can be no certainty that any firm offer will be made,” AbbVie said in a statement. “Discussions are no longer ongoing.”

The latest cash and share offer was equal to £46.26 a share, AbbVie said.

Shire’s shares rose 13 percent to £42.26 in trading in London on Friday morning.


Twitterfacebookprint
LATEST NEWS
14:37 Tajikistan plans to reduce poverty two-fold14:26 Bishkek voters passive in check of their information prior to elections14:16 All political parties bought votes in last parliamentary elections in Kyrgyzstan – NGO14:13 State Technical Safety Inspection of Kyrgyzstan bans sale of pyrotechnic products in bazaars13:23 OSCE welcomes restoration of license to Radio Ozodi journalists in Tajikistan13:14 Chief sanitary doctor expects stabilization of flu situation in Bishkek next week12:52 University of Toronto, University of Central Asia sign agreement on education, research collaboration12:40 Minibus worth 815,000 soms donated to children's neuropsychiatric hospital in Belovodskoe12:32 Human Rights Watch urges Kazakhstan to end move to shut down trade unions12:15 Angela Merkel calls for ban on full-face veils in Germany12:11 Kyrgyz government to finance agricultural sector for around $10 million in 201712:06 Uzbekistan cancels visa regime for tourists from 27 countries11:56 Slovakian company provides dynamic truck weighing systems for Kyrgyzstan11:46 New equipment delivered to Issyk-Kul regional dental clinic from France11:23 Quarantine declared in 65 schools, 7 kindergartens of Chui region over flu11:19 China, Kazakhstan pledge to enhance parliamentary cooperation11:10 MP suggests publication of list of terrorist organizations outlawed in Kyrgyzstan by national security agency11:06 Earthquake in Indonesia's Aceh province kills 2611:00 3 family members killed in Suzak10:43 Foreign Minister Abdyldayev to attend OSCE Annual Ministerial Council meeting in Hamburg
Astana
-10° C
Ashgabat
+5° C
Bishkek
+11° C
Dushanbe
+18° C
Tashkent
+14° C
Ulaanbaatar
-19° C
exchange rates
 
74.50
69.17
10.03
1.08
361.32
335.61
48.79
5.26
6.85
6.26
1.01
0.12
3286.53
2888.39
446.81
42.81
3.77
3.50
0.51
0.05

© AKIpress News Agency - 2001-2016. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75